These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38974908)

  • 1. Low serum HDL-cholesterol is associated with increased risk of the subcortical small vessel type of dementia.
    Axelsson Andrén E; Safi D; Wallin A; Svensson J
    Cereb Circ Cogn Behav; 2024; 6():100229. PubMed ID: 38974908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with the Subcortical Small Vessel Type of Dementia Have Disturbed Cardiometabolic Risk Profile.
    Axelsson E; Wallin A; Svensson J
    J Alzheimers Dis; 2020; 73(4):1373-1383. PubMed ID: 31929169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Performance of Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid-β Protein Precursor β in the Subcortical Small Vessel Type of Dementia.
    Axelsson Andrén E; Kettunen P; Bjerke M; Rolstad S; Zetterberg H; Blennow K; Wallin A; Svensson J
    J Alzheimers Dis; 2023; 96(4):1515-1528. PubMed ID: 37980667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.
    Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S
    PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report.
    Wallin A; Kapaki E; Boban M; Engelborghs S; Hermann DM; Huisa B; Jonsson M; Kramberger MG; Lossi L; Malojcic B; Mehrabian S; Merighi A; Mukaetova-Ladinska EB; Paraskevas GP; Popescu BO; Ravid R; Traykov L; Tsivgoulis G; Weinstein G; Korczyn A; Bjerke M; Rosenberg G
    BMC Neurol; 2017 May; 17(1):102. PubMed ID: 28535786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-brain barrier dysfunction and reduced cerebrospinal fluid levels of soluble amyloid precursor protein-β in patients with subcortical small-vessel disease.
    Kettunen P; Bjerke M; Eckerström C; Jonsson M; Zetterberg H; Blennow K; Svensson J; Wallin A
    Alzheimers Dement (Amst); 2022; 14(1):e12296. PubMed ID: 35356486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traditional and Non-traditional Lipid Profiles in Bosnian Patients with Probable Alzheimer's Disease and Vascular Dementia.
    Zaciragic A; Valjevac A; Dervisevic A; Fajkic A; Spahic S; Jadric R; Hasanbegovic I; Lepara O
    Med Arch; 2022 Aug; 76(4):267-272. PubMed ID: 36313955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of Dementia.
    Svensson J; Blomqvist M; Kettunen P; Eckerström C; Henricsson M; Jonsson M; Bjerke M; Månsson JE; Wallin A
    J Alzheimers Dis; 2021; 82(2):781-790. PubMed ID: 34092632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal and nonlinear relations of dietary and Serum cholesterol in midlife with cognitive decline: results from EMCOA study.
    An Y; Zhang X; Wang Y; Wang Y; Liu W; Wang T; Qin Z; Xiao R
    Mol Neurodegener; 2019 Dec; 14(1):51. PubMed ID: 31888696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in the Standard and Novel Lipid Profile Parameters Between Patients With Alzheimer's Disease and Vascular Dementia Stratified by the Degree of Cognitive Impairment.
    Zaciragic A; Dervisevic A; Valjevac A; Fajkic A; Spahic S; Hasanbegovic I; Jadric R; Lepara O
    Mater Sociomed; 2022 Jun; 34(2):100-106. PubMed ID: 36199842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease.
    Wallin A; Román GC; Esiri M; Kettunen P; Svensson J; Paraskevas GP; Kapaki E
    J Alzheimers Dis; 2018; 62(3):1417-1441. PubMed ID: 29562536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease.
    Pillai JA; Bena J; Bekris L; Kodur N; Kasumov T; Leverenz JB; Kashyap SR;
    Alzheimers Res Ther; 2023 Mar; 15(1):54. PubMed ID: 36927447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Triglyceride to high-density lipoprotein cholesterol ratio and incident of diabetes mellitus: a secondary retrospective analysis based on a Chinese cohort study.
    Chen Z; Hu H; Chen M; Luo X; Yao W; Liang Q; Yang F; Wang X
    Lipids Health Dis; 2020 Mar; 19(1):33. PubMed ID: 32131838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating metabolites and risk of incident dementia: A prospective cohort study.
    Huang SY; Zhang YR; Yang L; Li YZ; Wu BS; Chen SD; Feng JF; Dong Q; Cheng W; Yu JT
    J Neurochem; 2023 Dec; 167(5):668-679. PubMed ID: 37908051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative NMR-Based Lipoprotein Analysis Identifies Elevated HDL-4 and Triglycerides in the Serum of Alzheimer's Disease Patients.
    Berezhnoy G; Laske C; Trautwein C
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoproteins and HDL cholesterol do not associate with the risk of future dementia and Alzheimer's disease: the National Finnish population study (FINRISK).
    Tynkkynen J; Hernesniemi JA; Laatikainen T; Havulinna AS; Sundvall J; Leiviskä J; Salo P; Salomaa V
    Age (Dordr); 2016 Dec; 38(5-6):465-473. PubMed ID: 27663235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution and interaction of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and triglyceride to diabetes in hypertensive patients: A cross-sectional study.
    Hong M; Ling Y; Lu Z; Liu Y; Gu P; Shao J; Gao X; Li X
    J Diabetes Investig; 2019 Jan; 10(1):131-138. PubMed ID: 29694714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.
    Li G; Shofer JB; Kukull WA; Peskind ER; Tsuang DW; Breitner JC; McCormick W; Bowen JD; Teri L; Schellenberg GD; Larson EB
    Neurology; 2005 Oct; 65(7):1045-50. PubMed ID: 16217057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia.
    Poliakova T; Wellington CL
    Mol Neurodegener; 2023 Nov; 18(1):86. PubMed ID: 37974180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.